Full Text View
Tabular View
No Study Results Posted
Related Studies
The Early Reversibility of Rocuronium After Different Doses of Neostigmine
This study has been completed.
Study NCT00001520   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Paralysis
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
neostigmine
Additional drug interventions recognized in this trial
Neuromuscular Blocking Agents
Rocuronium
More general drug interventions related to this trial
Autonomic Agents
Cholinergic Agents
Cholinesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neuromuscular Agents
Neuromuscular Nondepolarizing Agents
Neurotransmitter Agents
Parasympathomimetics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institutes of Health Clinical Center (CC)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services